Plasminogen|cas:9001-91-6|西域试剂

Plasminogen

产品编号：Bellancom-P2821| CAS NO：9001-91-6

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	包装	价格	库存与货期	购买量	操作
Bellancom-P2821		￥14450.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Plasminogen

产品介绍

Plasminogen 是一种分泌性蛋白，在被尿激酶血浆蛋白原激活剂 (uPA) 或组织血浆蛋白原激活剂 (tPA) 裂解后，转化为血浆蛋白，一种能够裂解纤维蛋白和其他 ECM 成分的广泛的蛋白酶。Plasminogen 还是一种促炎调节剂，可加速急性和糖尿病伤口的愈合。Plasminogen 可用于伤口愈合，炎症以及低纤溶酶原血症的研究。

生物活性

Plasminogen is a secreted protein that upon cleavage by urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA) is converted to plasmin, a broad range protease capable of cleaving fibrin and other ECM components. Plasminogen also is a proinflammatory regulator that accelerates the healing of acute and diabetic wounds. Plasminogen can be used in studies of wound healing, inflammation and hypoplasminogenemia.

体外研究

体内研究

Plasminogen (plg) (2 mg/per; i.v.; single daily for 16 days) accelerates the healing of burn wounds in WT mice.
Plasminogen (plg) (2 mg/per; i.v.; single daily for 16 days) enhances the expression of IL-6 and augments the activation of STAT3 in wounded skin of both WT and plg-deficient mice.
Plasminogen (plg) (2 mg/per; i.v.; single daily for 24 days) improves the healing of burn wounds in a mouse model of diabetes.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	WT mice (plg-heterozygous (plg^+/-)) mice, plg^+/- and plg-deficient (plg^-/-) mice (C57BL/6 background; 8- to 10- week-old; burn-wound model).
Dosage:	2 mg/per
Administration:	Intravenous injection; single daily for 16 days.
Result:	Showed a significantly faster healing speed than control group at day 6, and the time to healing (ie, the scab falling off) was also approximately 2 days earlier than in the control group. Promoted epithelium layer fused to reepithelialize the wound completely, and only a small scab remained lightly attached above the wound when at day 11. Enhanced the level of IL-6 in the wounds of both WT and plg-deficient mice, and increased the pSTA T3 level in the wound.

Animal Model:	Genetically diabetic mice (C57BLKS db/db; at least 10 weeks old; with a minimal blood glucose level of 15 mM) and control heterozygous littermates (C57BLKS db/+; at least 10 weeks old; with a minimal blood glucose level of 7.8 mM).
Dosage:	2 mg/per
Administration:	Intravenous injection; single daily for 24 days.
Result:	Showed time to healing (ie, the scab falling off) was significantly earlier (approximately 3 days) than the control group. Accelerated the injured epithelium layer and the underlying tissue healed. (the front of the epithelium layer in the control group had barely fused and was covered by a scab. In addition, the tissue underneath the scab was inflamed).

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	WT mice (plg-heterozygous (plg^+/-)) mice, plg^+/- and plg-deficient (plg^-/-) mice (C57BL/6 background; 8- to 10- week-old; burn-wound model).
Dosage:	2 mg/per
Administration:	Intravenous injection; single daily for 16 days.
Result:	Showed a significantly faster healing speed than control group at day 6, and the time to healing (ie, the scab falling off) was also approximately 2 days earlier than in the control group. Promoted epithelium layer fused to reepithelialize the wound completely, and only a small scab remained lightly attached above the wound when at day 11. Enhanced the level of IL-6 in the wounds of both WT and plg-deficient mice, and increased the pSTA T3 level in the wound.

Animal Model:	Genetically diabetic mice (C57BLKS db/db; at least 10 weeks old; with a minimal blood glucose level of 15 mM) and control heterozygous littermates (C57BLKS db/+; at least 10 weeks old; with a minimal blood glucose level of 7.8 mM).
Dosage:	2 mg/per
Administration:	Intravenous injection; single daily for 24 days.
Result:	Showed time to healing (ie, the scab falling off) was significantly earlier (approximately 3 days) than the control group. Accelerated the injured epithelium layer and the underlying tissue healed. (the front of the epithelium layer in the control group had barely fused and was covered by a scab. In addition, the tissue underneath the scab was inflamed).